(Q34193869)

English

Effects of Orlistat, a Lipase Inhibitor, on the Pharmacokinetics of Three Highly Lipophilic Drugs (Amiodarone, Fluoxetine, and Simvastatin) in Healthy Volunteers

scientific article published on April 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

Effects of orlistat, a lipase inhibitor, on the pharmacokinetics of three highly lipophilic drugs (amiodarone, fluoxetine, and simvastatin) in healthy volunteers (English)

1 reference

Europe PubMed Central

31 July 2017

Effects of Orlistat, a Lipase Inhibitor, on the Pharmacokinetics of Three Highly Lipophilic Drugs (Amiodarone, Fluoxetine, and Simvastatin) in Healthy Volunteers (English)

1 reference

10.1177/0091270003252236

https://api.crossref.org/works/10.1177/0091270003252236

29 December 2023

triacylglycerol lipase inhibitor

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1177/0091270003252236

https://api.crossref.org/works/10.1177/0091270003252236

29 December 2023

author name string

Jianguo Zhi

1

1 reference

Europe PubMed Central

31 July 2017

Rema Moore

2

1 reference

Europe PubMed Central

31 July 2017

Linda Kanitra

3

1 reference

Europe PubMed Central

31 July 2017

Thomas E. Mulligan

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12723464

29 December 2023

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2003

1 reference

Europe PubMed Central

31 July 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1177%2F0091270003252236

1 reference

10.1177/0091270003252236

https://api.crossref.org/works/10.1177/0091270003252236

29 December 2023

https://accp1.onlinelibrary.wiley.com/doi/pdf/10.1177/0091270003252236

1 reference

10.1177/0091270003252236

https://api.crossref.org/works/10.1177/0091270003252236

29 December 2023

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

31 July 2017

43

1 reference

Europe PubMed Central

31 July 2017

428-435

1 reference

Europe PubMed Central

31 July 2017

4

1 reference

Europe PubMed Central

31 July 2017

Orlistat--a novel weight loss therapy

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252236

21 January 2018

The influence of orlistat on the pharmacokinetics and pharmacodynamics of glyburide in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252236

21 January 2018

Pharmacokinetic evaluation of the possible interaction between selected concomitant medications and orlistat at steady state in healthy subjects

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252236

21 January 2018

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252236

21 January 2018

Dramatic inhibition of amiodarone metabolism induced by grapefruit juice

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252236

21 January 2018

Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252236

21 January 2018

The influence of reduced dietary fat absorption induced by orlistat on the pharmacokinetics of digoxin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252236

21 January 2018

The effect of orlistat on the pharmacokinetics of phenytoin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252236

21 January 2018

The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252236

21 January 2018

Effect of the lipase inhibitor orlistat on the pharmacokinetics of four different antihypertensive drugs in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252236

21 January 2018

Lack of effect of orlistat on the bioavailability of a single dose of nifedipine extended-release tablets (Procardia XL) in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252236

21 January 2018

Lack of interaction between orlistat and oral contraceptives

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252236

21 January 2018

The effect of orlistat, an inhibitor of dietary fat absorption, on the pharmacokinetics of beta-carotene in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252236

21 January 2018

The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252236

21 January 2018

The interaction of the lipase inhibitor orlistat with ethanol in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252236

21 January 2018

Identifiers

10.1177/0091270003252236

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34193869&oldid=2039611679"